Counting the Costs of Drug-Related Adverse Events
Year of publication: |
1999
|
---|---|
Authors: | White, T. Jeffrey ; Arakelian, Annet ; Rho, Jay P. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 15.1999, 5, p. 445-458
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Reviews-on-treatment | Pharmacoeconomics | Adverse-reaction-monitoring | Cost-analysis | Hospitalisation | Mortality | Analgesics | Antibacterials | Anticoagulants | Digoxin | Contrast-media | Neuromuscular-blockers | Antiasthmatics | Antineoplastics | Antidepressants |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Meropenem: A Pharmacoeconomic Review of its Use in Serious Infections
Holliday, Stephen M., (1998)
-
Pharmacoeconomic Considerations in Treating Patients With Acute Leukaemia
Jonsson, Viggo, (1999)
-
Economic Aspects of Antibacterial Adverse Effects
Beringer, Paul M., (1998)
- More ...
-
Economic Aspects of Antibacterial Adverse Effects
Beringer, Paul M., (1998)
-
Economic Impact of Patient Adherence with Antidepressant Therapy Within a Managed Care Organization
White, T. Jeffrey, (2003)
-
White, T. Jeffrey, (2004)
- More ...